Kalkine has a fully transformed New Avatar.
Zynga Inc
Zynga Inc (Nasdaq: ZNGA) develops and markets social games on mobile platforms. It also generates revenue from advertising services and mobile game downloads.
Investment Rationale – SPECULATIVE BUY at USD 10.08
Risk Assessments
Recent News
Acquisition: On 5 May 2021, Zynga acquired Chartboost (mobile programmatic advertising and monetization platform) for nearly US$250 million in cash.
Financial Highlights for the quarter ended 31 March 2021 (as on 5 May 2021)
(Source: Company Website)
Share Price Chart
(Analysis done by Kalkine Group)
Valuation Methodology: EV/Sales Approach (FY21) (Illustrative)
Conclusion
Following the upbeat Q1 FY21 performance and Chartboost’s acquisition, Zynga is in a great position to increase the addressable market and generate a significant value for its shareholders. Moreover, the strength of live services portfolio, new game launches, strong momentum of the hyper-casual portfolio, and significant increase in DAUs shall help in achieving its long-term operating margin goals.
In terms of Q2 FY21 guidance, Zynga expects to report 49% year-on-year growth in revenue with 37% year-on-year growth in bookings.
(Source: Company Website)
The stock made a 52 week High and Low of USD 12.32 and USD 7.77, respectively. On the technical chart, the next important support level is at USD 8.27.
Based on the decent trading momentum, Chartboost’s acquisition, revenue and booking guidance, with support from valuation conducted above, we have given a “SPECULATIVE BUY” stance on Zynga Inc at the current price of USD 10.08 (as on 16 June 2021, at 9:55 AM ET), with a lower double-digit upside potential based 4.33x EV/Sales (approx.) on FY21E Sales (approx.).
Hexo Corp
Hexo Corp (NYSE: HEXO) is a consumer-packaged goods cannabis entity in Canada with global ambitions.
Investment Highlights – WATCH at USD 5.87
Key Risks
Recent News
Acquisition: On 1 June 2021, Hexo announced the closing of arrangements pertinent to the acquisition of outstanding stake in Zenabis, which is likely to provide accretive synergies.
Q3 FY21 Financial Highlights (for three months ended 30 April 2021, as of 14 June 2021)
(Source: Company website)
Share Price Chart
(Analysis done by Kalkine Group)
Conclusion
Hexo’s stalled revenue and continued losses amid strain cultivations and disrupted supply chain keeping the outlook gloomy. However, the Company has a dominant position in the Quebec province and a solid portfolio of cannabis patents filed in Canada. In the absence of guidance and lossmaking position, we are unable to punt on this stock presently. Notwithstanding, we will maintain a close watch over stock and will review the upcoming market catalysts. The stock made a 52-week High and Low of USD 11.04 and USD 2.32, respectively.
Based on weak fundamentals, macroeconomic uncertainties, lossmaking position, we have given a “Watch” stance on Hexo Corp at the current market price of USD 5.87 (as of 16 June 2021, at 9:40 AM ET), while we look forward to reviewing the FY21 results.
*All forecasted figures and Industry Information have been taken from REFINITIV.
*The reference data in this report has been partly sourced from REFINITIV.
*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached or if the price closes below the support level (indicative stop-loss price).
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.